Join
Live feed
·
PRReleasevia Quantisnow
LivaNova PLC logo

LivaNova Announces CORE-VNS 24-Month Data Show Adjunctive VNS Therapy is Associated with Substantial Reductions in Generalized Tonic-Clonic Seizures in People with Drug-Resistant Epilepsy

ByQuantisnow·Wall Street's wire, on your screen.
LIVN· LivaNova PLC
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LIVN (LivaNova PLC) and more on Quantisnow.